In 2002, heterozygous suppressor of fused variants (SUFU) in the germline were described to have a tumor suppressor role in the development of pediatric medulloblastoma (MB). Other neoplasms associated with pathologic germline SUFU variants have also been described among patients with basal cell nevus syndrome (BCNS; BCNS is also known as Gorlin syndrome, nevoid basal cell carcinoma [BCC] syndrome or Gorlin-Goltz syndrome; OMIM 109400), an autosomal-dominant cancer predisposition syndrome. The phenotype of patients with germline SUFU variants is very poorly characterized due to a paucity of large studies with long-term follow-up.
View Article and Find Full Text PDFObjectives: To conduct a systematic review of tranexamic acid (TXA) and the risk of renal failure from urinary clots in adult patients with hematuria.
Methods: A systematic review of Medline, Embase, CENTRAL, www.
Clinicaltrials: gov, and Google Scholar were searched.